Perimenopause Anxiety Treatment: Hormones, SSRIs and Non-Drug Options

Anxiety in perimenopause is treated with the same proven tools used for anxiety at any age, cognitive behavioral therapy (CBT) and SSRI or SNRI antidepressants, combined with treatment of the menopause symptoms that often drive it, such as hot flashes, night sweats and broken sleep. Hormone therapy is the most effective treatment for hot flashes, but no hormone product is FDA-approved to treat anxiety. The research on hormones and mood is real but limited, and it is mostly about depressive symptoms rather than anxiety disorders.

The most useful first step is sorting out what is happening: a new anxiety disorder, an old one returning, anxiety riding on poor sleep and night sweats, a medical cause, or depression that shows up as worry. Each points to a different starting treatment.

Why anxiety can rise during perimenopause

The Study of Women's Health Across the Nation (SWAN) followed 2,956 midlife women for 10 years. Women who had low anxiety before the transition were more likely to report high anxiety in early or late perimenopause and after menopause than before it, even after accounting for stressful life events, financial strain, health and hot flashes. Women who already had high anxiety tended to stay anxious throughout, without a specific rise tied to menopausal stage.

Several things often feed into it at once:

• Hot flashes and night sweats. In SWAN, frequent hot flashes and night sweats lasted a median of 7.4 years, and higher anxiety when they first appeared was linked to longer-lasting symptoms. The site's article on hot flashes, night sweats and the sleep cycle explains the loop.
• Sleep disruption, which lowers the threshold for worry and irritability.
• Midlife stressors: caring for children and aging parents, work pressure, relationship changes.
• A history of anxiety, depression or premenstrual mood symptoms.

Depression and anxiety often overlap here. Expert guidelines describe perimenopause as a window of vulnerability for depressive symptoms and major depression, often in combination with hot flashes and sleep problems. If low mood, loss of interest or hopelessness is part of your picture, read perimenopause depression: hormone therapy, antidepressants or both alongside this article.

If you are thinking about suicide or are in crisis, call or text 988 (the 988 Suicide & Crisis Lifeline) or go to the nearest emergency room.

First, rule out look-alikes

Palpitations, sweating, poor sleep and a racing mind are also symptoms of other conditions. Before calling it perimenopausal anxiety, a clinician will usually consider thyroid problems, anemia, heart rhythm problems, medication and supplement effects, caffeine and alcohol, and sleep apnea. The article on medical conditions to rule out before a psychiatric diagnosis lists the usual checks. Some women also notice ADHD symptoms becoming harder to manage in this stage; the site's article on how perimenopause can look like anxiety or ADHD covers that overlap.

The treatment options at a glance

Therapy: CBT and CBT for menopause

CBT is a well-studied, research-supported psychotherapy for anxiety disorders such as generalized anxiety disorder. It teaches you to notice and test anxious predictions, reduce avoidance and safety behaviors, and tolerate uncertainty. For panic attacks, it includes structured exposure to the body sensations that trigger fear, which is especially relevant when hot flashes and palpitations feel like the start of panic. The site's article on CBT for anxiety describes a typical course, and anxiety treatment options compared sets CBT beside medication.

A version adapted for menopause, called CBT-Meno, was tested in a randomized trial of 71 perimenopausal or postmenopausal women. Compared with a waitlist, it produced greater improvement in how much hot flashes interfered with life, depressive symptoms, sleep and sexual concerns, with gains maintained 3 months after treatment. The authors noted that its effect on anxiety itself still needs confirmation in further studies.

The Menopause Society's 2023 position statement on nonhormone therapy recommends CBT and clinical hypnosis for hot flashes and night sweats, at the highest level of evidence. That matters for anxiety, because fewer and less distressing night sweats usually means better sleep.

SSRIs and SNRIs: treating anxiety directly

If you meet criteria for an anxiety disorder, such as generalized anxiety disorder or panic disorder, antidepressants used for anxiety at any age are a standard option. Escitalopram, for example, is FDA-approved for generalized anxiety disorder in adults. The 2023 Menopause Society statement also lists SSRIs and SNRIs among recommended nonhormone treatments for hot flashes. One medication can therefore sometimes help both problems, although the dose and drug choice depend on which problem is primary.

Some practical points to raise with your prescriber:

• SSRIs take weeks to work, and the first weeks can bring nausea, sleep changes or a temporary rise in jitteriness.
• Sexual side effects can compound menopause-related sexual concerns; ask about this up front.
• If you take tamoxifen after breast cancer, drug choice matters: the paroxetine label warns that paroxetine may reduce tamoxifen's effectiveness by blocking the CYP2D6 enzyme. Your prescriber and oncologist should choose together.
• All antidepressants carry a boxed warning about suicidal thoughts and behaviors in children, teens and young adults.

For a closer comparison of two common choices, see sertraline vs escitalopram; for an option without sexual side effects that works differently, buspirone vs SSRIs.

Why low-dose paroxetine is not an anxiety treatment

Brisdelle is paroxetine at 7.5 mg taken at bedtime, approved for moderate to severe hot flashes. Its label states it is not indicated for any psychiatric condition and that its dose is lower than the paroxetine doses used for depression, OCD, panic disorder, generalized anxiety disorder, social anxiety disorder and PTSD. If anxiety is a main problem, it is not a substitute for anxiety treatment.

Hormone therapy: what it can and cannot do for anxiety

The Menopause Society's 2022 position statement calls hormone therapy the most effective treatment for hot flashes and night sweats. For women under 60 or within 10 years of menopause onset without contraindications, it judges the benefit-risk ratio favorable for bothersome hot flashes; for those starting later, it appears less favorable. In 2026, the FDA approved labeling changes that removed cardiovascular disease, breast cancer and probable dementia risk statements from the boxed warning on several hormone therapy products. Approved uses are still menopause symptoms and bone loss prevention, not anxiety.

On mood, the evidence is narrower than many headlines suggest:

• Expert guidelines on perimenopausal depression state that estrogen is not approved to treat it, but that there is evidence of antidepressant effects in perimenopausal women, particularly those with hot flashes. Data on estrogen plus progestin are sparse and inconclusive.
• A randomized trial of transdermal estradiol with intermittent micronized progesterone in 172 women aged 45 to 60 found fewer new cases of clinically significant depressive symptoms over 12 months than placebo (17.3% vs 32.3%), with the benefit seen in the early menopause transition but not later.
• These studies measured depressive symptoms. Rigorous trials of hormone therapy for diagnosed anxiety disorders are scarce, so using it to treat anxiety itself is not evidence-based on current data.

A reasonable way to think about it: if hot flashes and night sweats are clearly driving anxiety and poor sleep, treating them, with hormone therapy if it is safe for you, may ease anxiety indirectly. If anxiety was present before the transition or does not track with hot flashes, it needs anxiety treatment in its own right. That decision is best made with a clinician who can weigh both sides; a reproductive psychiatrist or a gynecologist working with a psychiatrist can help.

Nonhormonal hot flash medicines

Two newer drugs block brain signals involved in hot flashes. Fezolinetant (Veozah), approved in 2023, carries a boxed warning for liver injury: liver blood tests are required before starting and then monthly for the first 3 months and at 6 and 9 months. Elinzanetant (Lynkuet), approved in 2025, is taken at bedtime; its label warns about sleepiness and other nervous system effects, calls for liver testing before starting and again 3 months later, and also warns about a risk of seizures and of pregnancy loss. Both are approved only for moderate to severe hot flashes due to menopause. They may help anxiety indirectly by improving sleep and reducing night sweats, but they are not anxiety treatments.

The 2023 Menopause Society statement does not recommend supplements and herbal remedies for hot flashes, and it also does not recommend several popular approaches, such as mindfulness, yoga, exercise and avoiding triggers, for hot flash relief, citing limited or inconsistent evidence. Those habits can still be good for sleep, mood and general health; the point is that they have not been shown to stop hot flashes.

About benzodiazepines

Benzodiazepines such as lorazepam or alprazolam act quickly, which can make them tempting during a rough stretch. In 2020 the FDA required an updated boxed warning on all benzodiazepines about the risks of abuse, addiction, physical dependence and withdrawal reactions. Some prescribers use them briefly while an SSRI or therapy takes effect. Long-term daily use calls for a clear plan; hydroxyzine vs benzodiazepines compares the options.

Tracking symptoms makes the decision easier

Because perimenopause symptoms fluctuate, a few weeks of simple tracking often clarifies what is driving anxiety. Each day, note your anxiety level, any panic attacks, hours slept and night wakings, hot flashes or night sweats, your menstrual bleeding if you still have periods, and alcohol and caffeine. Bring the record to your appointment.

Patterns to look for: anxiety that peaks after nights of drenching sweats points toward treating hot flashes and sleep; anxiety that clusters in the days before bleeding suggests a cyclical, hormone-sensitive pattern worth raising; anxiety that is steady regardless of sleep or cycle suggests an anxiety disorder that needs direct treatment. Tracking also gives you a baseline, so you and your clinicians can see whether a change is actually helping.

Putting it together: common starting points

If insomnia has taken on a life of its own, CBT for insomnia is the first-line treatment; see insomnia treatment options.

Questions to ask your clinicians

• Do my symptoms fit an anxiety disorder, depression, menopause symptoms, or a mix?
• Have we checked thyroid, blood count and other medical causes?
• Is hormone therapy safe for me, and would it be aimed at hot flashes, sleep, or something else?
• If I start an SSRI or SNRI, which one fits my other medicines and my sexual health goals?
• Can my gynecologist and psychiatric prescriber share notes so the plan is coordinated?

How Dr. Lewis's practice approaches it

Dr. Lewis's practice combines psychiatric evaluation and medication management with psychotherapy, including CBT and DBT, lab testing, and nutrition and lifestyle psychiatry. The site's perimenopause psychiatry page has more about mental health care in this stage. A free discovery call by phone or text is a way to ask about care options, scheduling and insurance, and individual care starts with the Patient Interest Form. The practice is out of network with all insurance plans; if you need in-network care, ask the team on the discovery call about options. The Choosing Psychiatric Care guide covers other starting points.

Frequently asked questions

Can perimenopause cause panic attacks even if I never had them before?

New anxiety symptoms are more common during the transition in women who had low anxiety before, according to the SWAN study. Panic attacks should still be evaluated, because heart, thyroid and other causes can produce similar symptoms.

Will hormone therapy fix my anxiety?

It may help indirectly if hot flashes and night sweats are driving poor sleep and worry. Hormone therapy is not FDA-approved for anxiety, and the mood research mostly concerns depressive symptoms. Anxiety that persists needs its own treatment.

Can I take an SSRI and hormone therapy at the same time?

The two can be used together when your prescribers agree it is appropriate. Your gynecologist and psychiatric prescriber should both know everything you take.

Is Veozah or Lynkuet a treatment for anxiety?

No. Both are approved only for moderate to severe hot flashes due to menopause. They may improve sleep, which can ease anxiety, but they are not anxiety medications and both require liver monitoring.

Does perimenopause anxiety go away after menopause?

For some women it eases as hot flashes and sleep improve, but in SWAN, women who developed high anxiety during the transition were also more likely to have it after menopause. It is worth treating rather than waiting it out.

Do supplements help perimenopausal anxiety?

The Menopause Society does not recommend supplements and herbal remedies for hot flashes, and evidence for anxiety is limited. If you take any, tell your prescriber, because some interact with antidepressants.

Sources

1. Does risk for anxiety increase during the menopausal transition? Study of women's health across the nation. Menopause (Bromberger JT, et al.), 2013. pubmed.ncbi.nlm.nih.gov
2. Guidelines for the evaluation and treatment of perimenopausal depression: summary and recommendations. Menopause (Maki PM, et al.; NAMS and National Network of Depression Centers), 2018. pubmed.ncbi.nlm.nih.gov
3. The 2022 hormone therapy position statement of The North American Menopause Society. Menopause, 2022. pubmed.ncbi.nlm.nih.gov
4. The 2023 nonhormone therapy position statement of The North American Menopause Society. Menopause, 2023. pubmed.ncbi.nlm.nih.gov
5. Efficacy of Transdermal Estradiol and Micronized Progesterone in the Prevention of Depressive Symptoms in the Menopause Transition: A Randomized Clinical Trial. JAMA Psychiatry (Gordon JL, et al.), 2018. pubmed.ncbi.nlm.nih.gov
6. Cognitive behavior therapy for menopausal symptoms (CBT-Meno): a randomized controlled trial. Menopause (Green SM, et al.), 2019. pubmed.ncbi.nlm.nih.gov
7. BRISDELLE (paroxetine) capsules, prescribing information. U.S. National Library of Medicine DailyMed, 2025. dailymed.nlm.nih.gov
8. VEOZAH (fezolinetant) tablets, prescribing information. Astellas Pharma / U.S. National Library of Medicine DailyMed, 2026. dailymed.nlm.nih.gov
9. LYNKUET (elinzanetant) capsules, prescribing information. U.S. National Library of Medicine DailyMed, 2026. dailymed.nlm.nih.gov
10. LEXAPRO (escitalopram) tablets, prescribing information. U.S. National Library of Medicine DailyMed, 2024. dailymed.nlm.nih.gov
11. FDA Approves Labeling Changes to Menopausal Hormone Therapy Products. U.S. Food and Drug Administration, 2026. fda.gov
12. FDA requiring Boxed Warning updated to improve safe use of benzodiazepine drug class. U.S. Food and Drug Administration, 2020. fda.gov
13. Duration of menopausal vasomotor symptoms over the menopause transition. JAMA Internal Medicine (Avis NE, et al.), 2015. pubmed.ncbi.nlm.nih.gov
14. Generalized Anxiety Disorder: When Worry Gets Out of Control. National Institute of Mental Health, 2025. nimh.nih.gov

Educational information, not medical, tax or legal advice. Decisions about diagnosis, medication and treatment belong with a clinician who knows your history.